Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$935M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$606M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$598M |
| 4 |
Alibaba
BABA
|
+$340M |
| 5 |
SPDR Gold Trust
GLD
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$47.4M |
| 2 |
Linde
LIN
|
+$29.9M |
| 3 |
Walmart Inc
WMT
|
+$28.5M |
| 4 |
Microsoft
MSFT
|
+$28.4M |
| 5 |
Deere & Co
DE
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.27% |
| 2 | Consumer Discretionary | 16.92% |
| 3 | Healthcare | 15.14% |
| 4 | Financials | 5.73% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
ICU Medical
ICUI
$4.61B
| $4.57M | 0.03% |
19,591
-1,721
| -8% | -$361K |
|
302
GSK
GSK
$106B
| $4.57M | 0.03% |
95,712
+5,042
| +6% | +$253K |
|
303
Regeneron Pharmaceuticals
REGN
$80.8B
| $4.49M | 0.02% |
7,422
-5,263
| -41% | -$3.27M |
|
304
FIGS
FIGS
$2.37B
| $4.48M | 0.02% |
+120,713
| New | +$4.87M |
|
305
Invesco
IVZ
$13.9B
| $4.44M | 0.02% |
184,136
+43,735
| +31% | +$1.09M |
|
306
Astrana Health
ASTH
$1.77B
| $4.42M | 0.02% |
48,524
+4,912
| +11% | +$418K |
|
|
PINC
307
DELISTED
Premier
PINC
| $4.39M | 0.02% |
113,317
-9,767
| -8% | -$360K |
|
|
TWOU
308
DELISTED
2U Inc
TWOU
| $4.35M | 0.02% |
4,318
-137
| -3% | -$161K |
|
309
Health Catalyst
HCAT
$128M
| $4.32M | 0.02% |
86,400
+6,181
| +8% | +$337K |
|
310
Neogen
NEOG
$2.5B
| $4.31M | 0.02% |
99,243
-7,727
| -7% | -$336K |
|
311
East-West Bancorp
EWBC
$18B
| $4.3M | 0.02% |
55,485
+12,167
| +28% | +$885K |
|
312
HP
HPQ
$27.5B
| $4.28M | 0.02% |
156,250
-208,236
| -57% | -$5.98M |
|
313
AvalonBay Communities
AVB
$26.8B
| $4.23M | 0.02% |
19,078
+636
| +3% | +$143K |
|
|
TWNK
314
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $4.22M | 0.02% |
243,103
-10,979
| -4% | -$178K |
|
|
CMA
315
DELISTED
Comerica
CMA
| $4.2M | 0.02% |
52,207
+9,579
| +22% | +$689K |
|
316
Central Garden & Pet Co Class A
CENTA
$2.44B
| $4.2M | 0.02% |
122,129
-2,527
| -2% | -$87.4K |
|
317
Agilon Health
AGL
$1.6B
| $4.16M | 0.02% |
+6,343
| New | +$5.42M |
|
318
Western Alliance Bancorporation
WAL
$8.87B
| $4.15M | 0.02% |
+38,163
| New | +$3.71M |
|
319
Visteon
VC
$2.78B
| $4.13M | 0.02% |
43,762
+16,246
| +59% | +$1.75M |
|
|
VNET
320
VNET Group
VNET
$2.09B
| $4.11M | 0.02% |
237,254
+115,242
| +94% | +$2.15M |
|
321
Pricesmart
PSMT
$5.46B
| $4.11M | 0.02% |
52,948
-1,286
| -2% | -$109K |
|
322
Interparfums
IPAR
$3.94B
| $4M | 0.02% |
53,516
+6,851
| +15% | +$501K |
|
323
American Tower
AMT
$80.4B
| $3.95M | 0.02% |
+14,889
| New | +$4.24M |
|
324
West Fraser Timber
WFG
$5.65B
| $3.95M | 0.02% |
46,930
+2,967
| +7% | +$221K |
|
325
Spectrum Brands
SPB
$2.07B
| $3.94M | 0.02% |
41,233
-2,038
| -5% | -$173K |
|
Similar funds
Ray Dalio's Q3 2021 Portfolio in Review
As of Q3 2021, Ray Dalio held 821 positions worth $18.3B, up 17% from $15.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Ray Dalio deployed $3.42B of net new capital in Q3 2021, opening 117 new positions and adding to 343 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $47.4M trimmed.
- Ray Dalio's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 8,990,211 shares worth $70M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q3 2021, an estimated $935M increase.
- Ray Dalio's biggest Q3 2021 reduction was Danaher, cutting an estimated $47.4M.
- Ray Dalio fully exited Linde in Q3 2021, selling an estimated $29.9M.
- Ray Dalio's ten largest holdings make up 38% of its $18.3B portfolio in Q3 2021.
- Ray Dalio opened 117 new positions and closed 138 in Q3 2021.
- Ray Dalio's portfolio value rose 17% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q3 2021, filed 12 Nov 2021.